Weightloss RX Evaluation

 +
 +

CURRENT WEIGHT & LOSS GOAL

BMI Categories:
Underweight = <18.5
Normal weight = 18.5–24.9
Overweight = 25–29.9
Obesity = BMI of 30 or greater

HEALTH INFORMATION

Semaglutide Screening: Do you have any of the following conditions *
Are you pregnant or breastfeeding? *
Please describe your alcohol consumption : *
Please describe the closest "work-out" level: *
Mark the medical conditions that apply to you or any immediate family
 MyselfFamily history
Scarlet Fever
Meningitis
Infectious Mononucleosis
Tuberculosis
Exposure to TB
Malaria
Bronchitis
Pneumonia
Pleurisy
Hepatitis (yellow jaundice)
Bladder infections
Rheumatic fever
Kidney disease
Hives
Hay fever/sinusitis
Asthma
Emphysema
Arthritis
Back trouble
High blood pressure
Heart disease
Anemia
Bleeding tendency
Nose bleeds
Ulcer
Cancer
Hemorrhoids
Blood transfusion
Diabetes
Do you have any of the following conditions? *
PATIENT CONSENT FOR PHYSICIAN TO USE OR DISCLOSE HEALTH CARE INFORMATION FOR TREATMENT, PAYMENT, AND HEALTH CARE. *
I have recieved the HIPPA information *
clear
HIPPA I UNDERSTAND THAT MY HEALTH INFORMATION IS PRIVATE AND CONFIDENTIAL. I UNDERSTAND THAT B. Sweet WORKS VERY HARD TO PROTECT MY PRIVACY AND PRESERVE THE CONFIDENTIALITY OF MY PERSONAL HEALTH INFORMATION. I UNDERSTAND THAT SIGNING THIS DOCUMENT MEANS THAT B. SWEET MAY USE AND DISCLOSE MY PERSONAL HEALTH INFORMATION TO HELP PROVIDE HEALTH CARE TO ME, TO HANDLE BILLING AND PAYMENT, AND TO TAKE CARE OF OTHER HEALTH CARE OPERATIONS. FAILURE TO SIGN THIS CONSENT MAY RESULT IN THE PHYSICIAN DECLINING TO TREAT ME. UNDER THE TERMS OF THIS CONSENT, I CAN ASK B. SWEET TO RESTRICT HOW MY PERSONAL HEALTH INFORMATION IS USED OR DISCLOSED TO CARRY OUT TREATMENT, PAYMENT, OR HEALTH CARE OPERATIONS. I UNDERSTAND THAT B. SWEET / Beauty Bar Med-Spa DOES NOT HAVE TO AGREE TO MY REQUEST. IF HE DOES AGREE TO MY REQUEST, I UNDERSTAND THAT HE WOULD FOLLOW THE AGREED LIMITS. I UNDERSTAND THAT I HAVE THE RIGHT TO CANCEL THIS CONSENT IN WRITING AT ANY TIME. IF I DO CANCEL THE CONSENT, I UNDERSTAND THAT B. Sweet / Beauty bar Med-spa MAY HAVE ALREADY USED OR DISCLOSED INFORMATION ABOUT ME AND CANCELING THIS CONSENT WOULD NOT AFFECT THE INFORMATION ALREADY USED OR DISCLOSED. I MAY CANCEL THIS CONSENT AT ANY TIME BY DOING THE FOLLOWING: WRITING, SIGNING, AND DATING A LETTER TO B. SWEET MEDSPA THAT SAYS I WANT TO REVOKE MY CONSENT TO AUTHORIZE THE USE AND DISCLOSURE OF MY PERSONAL HEALTH INFORMATION FOR TREATMENT, PAYMENT, AND HEALTH CARE OPTIONS. I UNDERSTAND IF I CANCEL THIS CONSENT, B. SWEET / Beauty Bar Med-SpaIS NOT OBLIGATED TO PROVIDE FURTHER HEALTH CARE SERVICES TO ME. * *

POSSIBLE SIDE AFFECTS & EXPECTATIONS

When starting semaglutide, individuals may experience several effects related to its intended therapeutic action as well as potential side effects. Here's what people can generally expect when they begin taking semaglutide:

  1. Blood sugar management: Semaglutide works to lower blood sugar levels by stimulating insulin secretion and reducing glucagon secretion, both of which help to control blood sugar levels. People may notice improvements in their blood sugar levels over time.

  2. Weight loss: Semaglutide is associated with weight loss in many individuals. This effect can be noticeable, and some people may experience a significant reduction in body weight over time.

  3. Decreased appetite: Semaglutide can lead to a decrease in appetite, which contributes to its weight-loss effect. People may find that they feel less hungry and have fewer cravings for food.

  4. Injection site reactions: Redness, swelling, or itching at the injection site is common, especially initially. These reactions typically diminish over time.

  5. Gastrointestinal effects: Nausea, vomiting, diarrhea, or abdominal discomfort are common side effects when starting semaglutide. These symptoms often improve as the body adjusts to the medication.

  6. Improved glycemic control: With consistent use, people typically experience better control over their blood sugar levels, leading to reduced risks of diabetes-related complications.

  7. Routine monitoring: Regular monitoring of blood sugar levels and potential side effects is important when starting semaglutide. Healthcare providers may adjust the dosage or provide additional guidance based on individual responses to the medication.

  8. Other potential effects: Some individuals may experience less common side effects such as hypoglycemia, increased heart rate, or, rarely, more serious issues like pancreatitis or kidney problems.

 

 

Semaglutide is a medication used primarily for the treatment of type 2 diabetes. Like any medication, it can have side effects. Common side effects of semaglutide may include:

  1. Nausea: This is one of the most commonly reported side effects. It usually occurs when treatment is initiated and may decrease over time.

  2. Vomiting: Some individuals may experience vomiting as a side effect of semaglutide.

  3. Diarrhea: Changes in bowel habits, including diarrhea, may occur with semaglutide use.

  4. Abdominal pain: Some people may experience abdominal discomfort or pain while taking semaglutide.

  5. Constipation: In some cases, semaglutide may cause constipation.

  6. Decreased appetite: Semaglutide may lead to a decrease in appetite, which can result in weight loss.

  7. Hypoglycemia: While less common compared to some other diabetes medications like insulin or sulfonylureas, semaglutide can cause low blood sugar levels (hypoglycemia), especially when used in combination with other blood sugar-lowering medications.

  8. Injection site reactions: Redness, itching, or swelling at the injection site may occur.

  9. Increased heart rate: Some individuals may experience an increased heart rate (tachycardia) while taking semaglutide.

  10. Pancreatitis: In rare cases, semaglutide may cause inflammation of the pancreas (pancreatitis), which can be serious.

  11. Kidney problems: There have been reports of kidney problems associated with semaglutide use, including kidney failure.

  12. Thyroid tumors: In animal studies, semaglutide has been associated with an increased risk of thyroid tumors, although it's not clear if this risk applies to humans.

Semaglutide for weightloss is not covered under insurence but we do take FSA/HSA

I certify that the information I have provided above is accurate to the best of my knowledge. I have been made aware of the side affects and potential issues with this weightloss medication and would like to proceed with treatment if prescribed *
clear

Our Nurse Practitoner will contact you with follow up questions in the next 48 hours.

Powered byFormsite
Secured by Formsite